These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11363400)

  • 21. Success of combination therapy drives the push for earlier treatment.
    AIDS Alert; 1996 Jun; 11(6):61-4. PubMed ID: 11363540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The rolling uncertainties of antiprotease prescribing.
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1996 Feb; 2(2):6-10. PubMed ID: 11363341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protease inhibitor approved for AIDS treatment.
    AORN J; 1996 Sep; 64(3):453. PubMed ID: 8876926
    [No Abstract]   [Full Text] [Related]  

  • 25. Let there be drugs.
    Gilden D
    GMHC Treat Issues; 1996 Feb; 10(2):1, 13-6. PubMed ID: 11363380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indinavir (Crixivan).
    Treat Rev; 1996 Apr; (no 21):7. PubMed ID: 11363398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Man of the Year. Hope with an asterisk.
    Lacayo R
    Time; 1996 Dec 30-1997 Jan 6; 148(29):82-5. PubMed ID: 10163846
    [No Abstract]   [Full Text] [Related]  

  • 28. Overview of boosted protease inhibitors in treatment-experienced HIV-infected patients.
    Youle M
    J Antimicrob Chemother; 2007 Dec; 60(6):1195-205. PubMed ID: 17890281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ritonavir-boosted protease inhibitor monotherapy for the treatment of HIV-1 infection.
    Sahali S; Chaix ML; Delfraissy JF; Ghosn J
    AIDS Rev; 2008; 10(1):4-14. PubMed ID: 18385776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Saquinavir (Invirase): first protease inhibitor approved--reimbursement, information hotline numbers.
    James JS
    AIDS Treat News; 1995 Dec; (no 237):1-2. PubMed ID: 11363073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indinavir (Crixivan), Merck protease inhibitor, approved.
    James JS
    AIDS Treat News; 1996 Mar; (no 243):1-2. PubMed ID: 11363299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amprenavir approved.
    STEP Perspect; 1999; 99(2):8. PubMed ID: 11366753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Now there are eleven, but so what?
    Gilden D
    GMHC Treat Issues; 1997; 11(4/5):1-3. PubMed ID: 11364371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guidance offered in drug combination choices.
    AIDS Alert; 1997 Dec; 12(12):135-7. PubMed ID: 11364831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genotypic correlates of resistance to HIV-1 protease inhibitors on longitudinal data: the role of secondary mutations.
    Servais J; Plesséria JM; Lambert C; Fontaine E; Robert I; Arendt V; Staub T; Schneide F; Hemme R; Schmit JC
    Antivir Ther; 2001 Dec; 6(4):239-48. PubMed ID: 11878405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protease inhibitors and nucleoside combinations, or, Alice in Gaithersburg.
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1996 Apr; 2(4):23-32, 37. PubMed ID: 11363515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Top AIDS researchers' strategy for antiretroviral treatment.
    AIDS Alert; 1996 Sep; 11(9):97-100. PubMed ID: 11363728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New formulation of saquinavir (Fortovase) is more effective.
    Tam CW
    Fac Notes (New Orleans La); 1998; 10(2):11. PubMed ID: 11365126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolutionary analysis of HIV-1 protease inhibitors: Methods for design of inhibitors that evade resistance.
    Stoffler D; Sanner MF; Morris GM; Olson AJ; Goodsell DS
    Proteins; 2002 Jul; 48(1):63-74. PubMed ID: 12012338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolution of genotypic resistance to nucleoside analogues in patients receiving protease inhibitor-containing regimens.
    Pèrez-Olmeda M; Rubio A; Puig T; Gômez-Cano M; Ruiz L; Leal M; Clotet B; Soriano V
    Antivir Ther; 1999; 4(3):179-81. PubMed ID: 12731758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.